Skip to main content
SpringerLink
Log in

Comprehensive analyses refute link between BP meds and cancer

  • Clinical study
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

REFERENCE

  1. Bangalore S, Kumar S, Kjeldsen SE, Makani H, Grossman E, Wetterslev J, Gupta AK, Sever PS, Gluud C, Messerli FH.Antihypertensive drugs and risk of cancer: network meta-analyses and trialsequential analyses of 324 168 participants from randomised trials. Lancet Oncology: 29 Nov 2010. Available from: URL: http://dx.doi.org/10.1016/s1470-2045(10)70260-6

  2. Lindholm LH, Carlberg B.Blood-pressure drugs and cancer: much ado about nothing? Lancet Oncology: 29 Nov 2010. Available from: URL: http://dx.doi.org/10.1016/s1470-2045(10)70271-0

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Comprehensive analyses refute link between BP meds and cancer. React. Wkly. 1332, 4 (2010). https://doi.org/10.2165/00128415-201013320-00010

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00128415-201013320-00010

Keywords

Search

Navigation